Farvid Maryam Sadat, Jalali Mahmoud, Siassi Fereydoun, Hosseini Mostafa
Department of Community Nutrition, School of Nutrition and Food Technology, Shaheed Beheshti University of Medical Sciences, P.O. Box 19395-4741, Tehran, Iran.
Diabetes Care. 2005 Oct;28(10):2458-64. doi: 10.2337/diacare.28.10.2458.
The present study was designed to assess the effect of magnesium plus zinc, vitamins C plus E, and a combination of these micronutrients on nephropathy indexes in type 2 diabetic patients.
In a randomized, double-blind, placebo-controlled clinical trial, 69 type 2 diabetic patients were randomly divided into four groups, each group receiving one of the following daily supplement for 3 months: group M (n = 16), 200 mg Mg and 30 mg Zn; group V (n = 18), 200 mg vitamin C and 100 IU vitamin E; group MV (n = 17), minerals plus vitamins; and group P (n = 18), placebo. Urinary albumin excretion and N-acetyl-beta-d-glucosaminidase activity (NAG) in urine were determined at the beginning and at the end of the trial. Treatment effects were analyzed by general linear modeling.
Results indicate that after 3 months of supplementation, levels of urinary albumin excretion decreased in the V and MV groups (P = 0.034 and P = 0.005, respectively). Urinary NAG activity did not significantly change in any treatment groups. Levels of systolic, diastolic, and mean blood pressure significantly decreased in the MV group (P = 0.008, P = 0.017, and P = 0.009, respectively). Also, combination of vitamin and mineral supplementation had significant effects in decreasing fasting serum glucose (P = 0.035) and malondialdehyde concentrations (P = 0.004) and in increasing HDL cholesterol and apolipoprotein A1 levels (P = 0.019). There was no significant change in the levels of these parameters in the other three groups.
In conclusion, the results of the present study provide evidence for the effects of vitamins C and E and also combination of magnesium, zinc, and vitamins C and E supplementation on improvement of glomerular but not tubular renal function in type 2 diabetic patients.
本研究旨在评估镁加锌、维生素C加E以及这些微量营养素的组合对2型糖尿病患者肾病指标的影响。
在一项随机、双盲、安慰剂对照的临床试验中,69名2型糖尿病患者被随机分为四组,每组每天接受以下一种补充剂,为期3个月:M组(n = 16),200毫克镁和30毫克锌;V组(n = 18),200毫克维生素C和100国际单位维生素E;MV组(n = 17),矿物质加维生素;P组(n = 18),安慰剂。在试验开始和结束时测定尿白蛋白排泄量和尿中N - 乙酰 - β - D - 氨基葡萄糖苷酶活性(NAG)。通过一般线性模型分析治疗效果。
结果表明补充3个月后,V组和MV组的尿白蛋白排泄水平下降(分别为P = 0.034和P = 0.005)。任何治疗组的尿NAG活性均无显著变化。MV组的收缩压、舒张压和平均血压水平显著下降(分别为P = 0.008、P = 0.017和P = 0.009)。此外,维生素和矿物质联合补充对降低空腹血糖(P = 0.035)和丙二醛浓度(P = 0.004)以及提高高密度脂蛋白胆固醇和载脂蛋白A1水平(P = 0.019)有显著效果。其他三组这些参数的水平无显著变化。
总之,本研究结果为维生素C和E以及镁、锌与维生素C和E联合补充对改善2型糖尿病患者肾小球而非肾小管肾功能的作用提供了证据。